Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: lessons from a Malaria vaccine trial substudy by Ford, T, Wenden, C, Mbekeani, A, Dally, L, Cox, J, Morin, M, Winstone, N, Hill, A, Gilmour, J, Ewer, K

A phase 1 human immunodeficiency virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime-boost v... by Kratochvil, S, McKay, P, Kopycinski, J, Bishop, C, Hayes, P, Muir, L, Pinder, C, Cizmeci, D, King, D, Aldon, Y, Wines, B, Hogarth, P, Chung, A, Kent, S, Held, K, Geldmacher, C, Dally, L, Santos, N, Cole, T, Gilmour, J, Fidler, S, Shattock, R

Corrigendum to "Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to in... by Guimarães-Walker, A, Mackie, N, McCormack, S, Hanke, T, Schmidt, C, Gilmour, J, Barin, B, McMichael, A, Weber, J, Legg, K, Babiker, A, Hayes, P, Gotch, F, Smith, C, Dally, L, Dorrell, L, Cebere, I, Kay, R, Winstone, N, Moore, S, Goonetilleke, N, Fast, P

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 speci... by Guimarães-Walker, A, Mackie, N, McCormack, S, Hanke, T, Schmidt, C, Gilmour, J, Barin, B, McMichael, A, Weber, J, Legg, K, Babiker, A, Hayes, P, Gotch, F, Smith, C, Dally, L, Dorrell, L, Cebere, I, Kay, R, Winstone, N, Moore, S, Goonetilleke, N, Fast, P

Corrigendum to " Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to i... by Guimarães-Walker, A, Mackie, N, McCormack, S, Hanke, T, Schmidt, C, Gilmour, J, Barin, B, McMichael, A, Weber, J, Legg, K, Babiker, A, Hayes, P, Gotch, F, Smith, C, Dally, L, Dorrell, L, Cebere, I, Kay, R, Winstone, N, Moore, S, Goonetilleke, N, Fast, P

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 speci... by Guimaraes-Walker, A, Mackie, N, McCormack, S, Hanke, T, Schmidt, C, Gilmour, J, Barin, B, McMichael, A, Weber, J, Legg, K, Babiker, A, Hayes, P, Gotch, F, Smith, C, Dally, L, Dorrell, L, Cebere, I, Kay, R, Winstone, N, Moore, S, Goonetilleke, N, Fast, P, Grp, I

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials. by Stevens, W, Kamali, A, Karita, E, Anzala, O, Sanders, E, Jaoko, W, Kaleebu, P, Mulenga, J, Dally, L, Fast, P, Gilmour, J, Farah, B, Birungi, J, Hughes, P, Manigart, O, Stevens, G, Yates, S, Thomson, H, von Lieven, A, Krebs, M, Price, M, Stoll-Johnson, L, Ketter, N

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. by Jaoko, W, Nakwagala, F, Anzala, O, Manyonyi, G, Birungi, J, Nanvubya, A, Bashir, F, Bhatt, K, Ogutu, H, Wakasiaka, S, Matu, L, Waruingi, W, Odada, J, Oyaro, M, Indangasi, J, Ndinya-Achola, J, Konde, C, Mugisha, E, Fast, P, Schmidt, C, Gilmour, J, Tarragona, T, Smith, C, Barin, B, Dally, L

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenici... by Peters, B, Jaoko, W, Vardas, E, Panayotakopoulos, G, Fast, P, Schmidt, C, Gilmour, J, Bogoshi, M, Omosa-Manyonyi, G, Dally, L, Klavinskis, L, Farah, B, Tarragona, T, Bart, P, Robinson, A, Pieterse, C, Stevens, W, Thomas, R, Barin, B, Mcmichael, A, McIntyre, J, Pantaleo, G, Hanke, T, Bwayo, J

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and mo... by Goonetilleke, N, Moore, S, Dally, L, Winstone, N, Cebere, I, Mahmoud, A, Pinheiro, S, Gillespie, G, Brown, D, Loach, V, Roberts, J, Guimaraes-Walker, A, Hayes, P, Loughran, K, Smith, C, De Bont, J, Verlinde, C, Vooijs, D, Schmidt, C, Boaz, M, Gilmour, J, Fast, P, Dorrell, L, Hanke, T, Mcmichael, A

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults by Mutua, G, Farah, B, Langat, R, Indangasi, J, Ogola, S, Onsembe, B, Kopycinski, J, Hayes, P, Borthwick, N, Ashraf, A, Dally, L, Barin, B, Tillander, A, Gilmour, J, De Bont, J, Crook, A, Hannaman, D, Cox, J, Anzala, O, Fast, P, Reilly, M, Chinyenze, K, Jaoko, W, Hanke, T, HIV-CORE 004 study group

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. by Karita, E, Ketter, N, Price, M, Kayitenkore, K, Kaleebu, P, Nanvubya, A, Anzala, O, Jaoko, W, Mutua, G, Ruzagira, E, Mulenga, J, Sanders, E, Mwangome, M, Allen, S, Bwanika, A, Bahemuka, U, Awuondo, K, Omosa, G, Farah, B, Amornkul, P, Birungi, J, Yates, S, Stoll-Johnson, L, Gilmour, J, Stevens, G, Shutes, E, Manigart, O, Hughes, P, Dally, L, Scott, J, Stevens, W, Fast, P, Kamali, A